Bone Biologics (BBLG) Restructuring Costs (2013)
Bone Biologics (BBLG) reported Restructuring Costs of $30.0 for Q4 2013, little changed quarter-over-quarter from $30.0 in Q3 2013.
Bone Biologics (BBLG) Restructuring Costs (2013) Analysis & Trends
Bone Biologics (BBLG) has 1 years of Restructuring Costs data on file, last reported at $30.0 in Q4 2013.
- Restructuring Costs for Q4 2013 came in at $30.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2013 was $120.0 (changed N/A YoY), and the FY2013 annual result was $120.0, changed N/A from the prior year.
- Restructuring Costs was little changed at $30.0 in Q4 2013 per BBLG's latest filing, from $30.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $30.0 in Q1 2013 and troughed at $30.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2013 | 30.00 |
| Jul 31, 2013 | 30.00 |
| Apr 30, 2013 | 30.00 |
| Jan 31, 2013 | 30.00 |